RECRUITING

Prospective Data Bank Creation to Study Vaginal Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.

Official Title

A Prospective Longitudinal Data Bank Creation to Study Vaginal Conditions With a Novel Diagnostic Approach

Quick Facts

Study Start:2013-04
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01829204

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 75 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients willing to participate, and give informed consent, and
  2. * Asymptomatic, non-pregnant, healthy women ages 21 to 75 years with no previous history of any chronic or recurrent vulvovaginal condition who attend our clinical offices for their annual well-woman physical examination.
  3. * Non-pregnant women ages 21 to 75 years being evaluated for any gynecological vulvovaginal condition.
  4. * Pregnant women ages 21 to 75 years who are both asymptomatic and healthy
  5. * Pregnant women ages 21 to 75 who have any gynecological vulvovaginal condition
  1. * Asymptomatic patients ages \< 21 or \> 75, or symptomatic patients ages \< 21 or \> 75 years.
  2. * Patients diagnosed with cancer or having any medical condition that is not under control including: diabetes mellitus, hypertension, collagen disease, hemoglobinopathy, renal insufficiency, depression, anxiety, psychosis and panic attacks
  3. * Patients unable to follow the protocol or unwilling to participate

Contacts and Locations

Principal Investigator

Michael L Galloway, DO
PRINCIPAL_INVESTIGATOR
TTUHSC PB

Study Locations (Sites)

TTUHSC Permian Basin
Midland, Texas, 79701
United States

Collaborators and Investigators

Sponsor: Texas Tech University Health Sciences Center

  • Michael L Galloway, DO, PRINCIPAL_INVESTIGATOR, TTUHSC PB

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2013-04
Study Completion Date2027-12

Study Record Updates

Study Start Date2013-04
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Vulvodynia
  • Mycoses
  • Bacterial Vaginosis
  • Preterm Labor